Quarterly report · Q1
7459.TEDINET S100OYEC
Period2022-04-01 → 2022-06-30
Filed2022-08-10
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 34
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥838.3bn | 2022-04-01 → 2022-06-30 | Cons. | Net sales |
| Revenue | ¥3.29T | 2021-04-01 → 2022-03-31 | Cons. | Net sales (5-year summary) |
| Revenue | ¥824.9bn | 2021-04-01 → 2021-06-30 | Cons. | Net sales |
| Operating income | ¥13.5bn | 2022-04-01 → 2022-06-30 | Cons. | Operating income |
| Operating income | ¥13.3bn | 2021-04-01 → 2021-06-30 | Cons. | Operating income |
| Ordinary income | ¥17.6bn | 2022-04-01 → 2022-06-30 | Cons. | Ordinary income |
| Ordinary income | ¥62.0bn | 2021-04-01 → 2022-03-31 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥17.4bn | 2021-04-01 → 2021-06-30 | Cons. | Ordinary income |
| Profit before tax | ¥17.2bn | 2022-04-01 → 2022-06-30 | Cons. | Income before income taxes |
| Profit before tax | ¥17.5bn | 2021-04-01 → 2021-06-30 | Cons. | Income before income taxes |
| Net income (owners) | ¥8.3bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥29.4bn | 2021-04-01 → 2022-03-31 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥9.4bn | 2021-04-01 → 2021-06-30 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥10.8bn | 2022-04-01 → 2022-06-30 | Cons. | Profit loss |
| Net income | ¥12.2bn | 2021-04-01 → 2021-06-30 | Cons. | Profit loss |
| Total assets | ¥1.72T | at 2022-06-30 | Cons. | Assets |
| Total assets | ¥1.71T | at 2022-03-31 | Cons. | Assets |
| Total assets | ¥1.70T | at 2021-06-30 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥1.06T | at 2022-06-30 | Cons. | Liabilities |
| Total liabilities | ¥1.06T | at 2022-03-31 | Cons. | Liabilities |
| Net assets / equity | ¥659.0bn | at 2022-06-30 | Cons. | Net assets |
| Net assets / equity | ¥649.1bn | at 2022-03-31 | Cons. | Net assets |
| Net assets / equity | ¥645.5bn | at 2021-06-30 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥218.8bn | at 2022-06-30 | Cons. | Cash and deposits |
| Cash and deposits | ¥243.2bn | at 2022-03-31 | Cons. | Cash and deposits |
| EPS (basic) | ¥39.39 | 2022-04-01 → 2022-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥140.14 | 2021-04-01 → 2022-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥44.99 | 2021-04-01 → 2021-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥36.94 | 2022-04-01 → 2022-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥131.41 | 2021-04-01 → 2022-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥42.22 | 2021-04-01 → 2021-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 31.4% | at 2022-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.0% | at 2022-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 31.1% | at 2021-06-30 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 38
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-06-30 | −¥913m |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-06-30 | −¥913m |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-06-30 | ¥98m |
| jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥18.5bn |
| jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥18.5bn |
| jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥1m |
| jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥692m |
| jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥276.2bn |
| jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥276.2bn |
| jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥94m |
| jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥6.5bn |
| jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue | 2022-04-01 → 2022-06-30 | ¥544.4bn |
| jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue external | 2022-04-01 → 2022-06-30 | ¥543.6bn |
| jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥817m |
| jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | segment profit | 2022-04-01 → 2022-06-30 | ¥6.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-04-01 → 2022-06-30 | ¥839.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-04-01 → 2022-06-30 | ¥838.3bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2022-04-01 → 2022-06-30 | ¥913m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-04-01 → 2022-06-30 | ¥13.4bn |
| Reconciling Itemsreconciling | revenue | 2021-04-01 → 2021-06-30 | −¥937m |
| Reconciling Itemsreconciling | revenue intersegment | 2021-04-01 → 2021-06-30 | −¥937m |
| Reconciling Itemsreconciling | segment profit | 2021-04-01 → 2021-06-30 | ¥169m |
| jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥18.1bn |
| jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥18.1bn |
| jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥0 |
| jpcrp040300-q1r_E02632-000Animal Health Products And Food Processing Raw Materials Wholesale Businessreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥734m |
| jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥269.7bn |
| jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥269.6bn |
| jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥90m |
| jpcrp040300-q1r_E02632-000Cosmetics Daily Necessities And OTC Pharmaceutical Wholesale Businessreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥7.0bn |
| jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue | 2021-04-01 → 2021-06-30 | ¥538.0bn |
| jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue external | 2021-04-01 → 2021-06-30 | ¥537.1bn |
| jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥846m |
| jpcrp040300-q1r_E02632-000Prescription Pharmaceutical Wholesale Businessreportable segment | segment profit | 2021-04-01 → 2021-06-30 | ¥5.4bn |
| Total Of Reportable Segments And Otherssegment total | revenue | 2021-04-01 → 2021-06-30 | ¥825.8bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2021-04-01 → 2021-06-30 | ¥824.9bn |
| Total Of Reportable Segments And Otherssegment total | revenue intersegment | 2021-04-01 → 2021-06-30 | ¥937m |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2021-04-01 → 2021-06-30 | ¥13.1bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 379
| Item | Context | Value | Unit |
|---|---|---|---|
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社メディパルホールディングス | |
| Company name in english cover page | FilingDateInstant | MEDIPAL HOLDINGS CORPORATION | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 渡辺 秀一 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)東京都中央区八重洲二丁目７番15号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)０３（３５１７）５８００（代表) | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)常務取締役管理本部長 左近 祐史 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)東京都中央区八重洲二丁目７番15号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | Original text (Japanese)０３（３５１７）５８００（代表） | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)常務取締役管理本部長 左近 祐史 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E02632 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 74590 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社メディパルホールディングス | |
| Filer name in english | FilingDateInstant | MEDIPAL HOLDINGS CORPORATION | |
| Fund name in japanese | FilingDateInstant | － | |
| Fund name in english | FilingDateInstant | － | |
| Cabinet office ordinance | FilingDateInstant | Original text (Japanese)企業内容等の開示に関する内閣府令 | |
| Document type | FilingDateInstant | Original text (Japanese)第四号の三様式 | |
| Accounting standards | FilingDateInstant | Japan GAAP | |
| Whether consolidated financial statements are prepared | FilingDateInstant | true | |
| Industry code when consolidated financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | CTE | |
| Industry code when financial statements are prepared in accordance with industry specific regulations | FilingDateInstant | － | |
| Current fiscal year start date | FilingDateInstant | 2022-04-01 | |
| Current period end date | FilingDateInstant | 2022-06-30 | |
| Type of current period | FilingDateInstant | Q1 | |
| Current fiscal year end date | FilingDateInstant | 2023-03-31 | |
| Previous fiscal year start date | FilingDateInstant | 2021-04-01 | |
| Comparative period end date | FilingDateInstant | 2021-06-30 | |
| Previous fiscal year end date | FilingDateInstant | 2022-03-31 | |
| Next fiscal year start date | FilingDateInstant | － | |
| End date of quarterly or semi annual period of next fiscal year | FilingDateInstant | － | |
| Amendment flag | FilingDateInstant | false | |
| Identification of document subject to amendment | FilingDateInstant | － | |
| Report amendment flag | FilingDateInstant | false | |
| Xbrl amendment flag | FilingDateInstant | false | |
| Business results of group (text) | FilingDateInstant | Text · Plus | |
| Description of business (text) | FilingDateInstant | Text · Plus | |
| Business risks (text) | FilingDateInstant | Text · Plus | |
| Management analysis of financial position operating results and cash flows (text) | FilingDateInstant | Text · Plus | |
| Critical contracts for operation (text) | FilingDateInstant | Text · Plus | |
| Total number of shares (text) | FilingDateInstant | Text · Plus | |
| Issued shares total number of shares etc (text) | FilingDateInstant | Text · Plus | |
| Class issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)普通株式 | |
| Name of financial instruments exchange on which securities are listed or authorized financial instruments business association to which securities are registered | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)東京証券取引所プライム市場 | |
| Description issued shares total number of shares etc | FilingDateInstant_OrdinaryShareMember | Original text (Japanese)単元株式数100株 | |
| Details of employee share option program (text) | FilingDateInstant | Text · Plus | |
| Other information on share acquisition rights (text) | FilingDateInstant | Text · Plus | |
| Exercises etc of moving strike convertible bonds etc (text) | FilingDateInstant | Text · Plus | |
| Changes in number of issued shares stated capital etc (text) | FilingDateInstant | Text · Plus |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 12 of 12 passed
| balance sheet identity | pass rounding |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |